Insulinotropic glucagonlike peptide-I(7–37)/(7–36)amide A new incretin hormone
Intestinal peptide hormones, released into circulation in response to a meal, are important augmentors of the postprandial insulin release stimulated by absorbed nutrients. In this “Incretin concept” glucagon-like peptide I(7–37) plays a major role because it is the most powerful glucose-dependent i...
Gespeichert in:
| Veröffentlicht in: | Trends in Endocrinology & Metabolism 1992-07, Vol.3 (5), p.158-163 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 163 |
|---|---|
| container_issue | 5 |
| container_start_page | 158 |
| container_title | Trends in Endocrinology & Metabolism |
| container_volume | 3 |
| creator | Fehmann, Hans-C. Habener, Joel F. |
| description | Intestinal peptide hormones, released into circulation in response to a meal, are important augmentors of the postprandial insulin release stimulated by absorbed nutrients. In this “Incretin concept” glucagon-like peptide I(7–37) plays a major role because it is the most powerful glucose-dependent insulin secretagogue described so far. Glucagonlike peptide I(7–37) also stimulates proinsulin gene expression and proinsulin biosynthesis in insulinoma cells, and it may be involved in the regulation of the intracellular insulin pool of the B cell. Recent studies show elevated levels of glucagonlike peptide I(7–37) in patients with non-insulin-dependent diabetes mellitus. The physiology and pathophysiology of the enteroinsular axis is a promising field of basic and clinical research that has a relevance to diabetes mellitus. |
| doi_str_mv | 10.1016/1043-2760(92)90165-W |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734283375</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>104327609290165W</els_id><sourcerecordid>734283375</sourcerecordid><originalsourceid>FETCH-LOGICAL-c303t-c571c47f75bb02591a2ff646953c09bdb907ee77c5fecb3923a51b9de01831a13</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMoXkbfQKQLQWdRJ2maptkIg3gZEARRXIY0PdVom9SkVdz5Dr6hT2LHGXXn6vwcvnPhQ2iX4COCSTYhOKVxwjN8KJKxGDosvltBmyTnIqY4I6tD_kE20FYIjxiTNCdsHW2QPMUcC7aJrmc29LWxrvOuNTq6r3ut7p2tzRNELbSdKSGeHfLP9w_Kx5NFyMaqGfrRNLLwGhmrPXTGRg_ON87CNlqrVB1gZ1lH6Pbs9ObkIr68Op-dTC9jTTHtYs040SmvOCsKnDBBVFJVWZoJRjUWRVkIzAE416wCXVCRUMVIIUrAJKdEETpCB4u9rXfPPYRONiZoqGtlwfVBcpomOaWcDWS6ILV3IXioZOtNo_ybJFjOZcq5KTk3JUUiv2XKu2Fsb3mgLxoo_4aW9gZgfwmooFVdeWW1Cb8co1mep2LAjhcYDDZeDHgZtAGroTQedCdLZ_5_5AtMzJBo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734283375</pqid></control><display><type>article</type><title>Insulinotropic glucagonlike peptide-I(7–37)/(7–36)amide A new incretin hormone</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Fehmann, Hans-C. ; Habener, Joel F.</creator><creatorcontrib>Fehmann, Hans-C. ; Habener, Joel F.</creatorcontrib><description>Intestinal peptide hormones, released into circulation in response to a meal, are important augmentors of the postprandial insulin release stimulated by absorbed nutrients. In this “Incretin concept” glucagon-like peptide I(7–37) plays a major role because it is the most powerful glucose-dependent insulin secretagogue described so far. Glucagonlike peptide I(7–37) also stimulates proinsulin gene expression and proinsulin biosynthesis in insulinoma cells, and it may be involved in the regulation of the intracellular insulin pool of the B cell. Recent studies show elevated levels of glucagonlike peptide I(7–37) in patients with non-insulin-dependent diabetes mellitus. The physiology and pathophysiology of the enteroinsular axis is a promising field of basic and clinical research that has a relevance to diabetes mellitus.</description><identifier>ISSN: 1043-2760</identifier><identifier>EISSN: 1879-3061</identifier><identifier>DOI: 10.1016/1043-2760(92)90165-W</identifier><identifier>PMID: 18407095</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Fundamental and applied biological sciences. Psychology ; Gastrointestinal hormones ; Vertebrates: digestive system</subject><ispartof>Trends in Endocrinology & Metabolism, 1992-07, Vol.3 (5), p.158-163</ispartof><rights>1992</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c303t-c571c47f75bb02591a2ff646953c09bdb907ee77c5fecb3923a51b9de01831a13</citedby><cites>FETCH-LOGICAL-c303t-c571c47f75bb02591a2ff646953c09bdb907ee77c5fecb3923a51b9de01831a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/1043-2760(92)90165-W$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>313,314,780,784,792,3550,27922,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5368849$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18407095$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fehmann, Hans-C.</creatorcontrib><creatorcontrib>Habener, Joel F.</creatorcontrib><title>Insulinotropic glucagonlike peptide-I(7–37)/(7–36)amide A new incretin hormone</title><title>Trends in Endocrinology & Metabolism</title><addtitle>Trends Endocrinol Metab</addtitle><description>Intestinal peptide hormones, released into circulation in response to a meal, are important augmentors of the postprandial insulin release stimulated by absorbed nutrients. In this “Incretin concept” glucagon-like peptide I(7–37) plays a major role because it is the most powerful glucose-dependent insulin secretagogue described so far. Glucagonlike peptide I(7–37) also stimulates proinsulin gene expression and proinsulin biosynthesis in insulinoma cells, and it may be involved in the regulation of the intracellular insulin pool of the B cell. Recent studies show elevated levels of glucagonlike peptide I(7–37) in patients with non-insulin-dependent diabetes mellitus. The physiology and pathophysiology of the enteroinsular axis is a promising field of basic and clinical research that has a relevance to diabetes mellitus.</description><subject>Biological and medical sciences</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gastrointestinal hormones</subject><subject>Vertebrates: digestive system</subject><issn>1043-2760</issn><issn>1879-3061</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKxDAUhoMoXkbfQKQLQWdRJ2maptkIg3gZEARRXIY0PdVom9SkVdz5Dr6hT2LHGXXn6vwcvnPhQ2iX4COCSTYhOKVxwjN8KJKxGDosvltBmyTnIqY4I6tD_kE20FYIjxiTNCdsHW2QPMUcC7aJrmc29LWxrvOuNTq6r3ut7p2tzRNELbSdKSGeHfLP9w_Kx5NFyMaqGfrRNLLwGhmrPXTGRg_ON87CNlqrVB1gZ1lH6Pbs9ObkIr68Op-dTC9jTTHtYs040SmvOCsKnDBBVFJVWZoJRjUWRVkIzAE416wCXVCRUMVIIUrAJKdEETpCB4u9rXfPPYRONiZoqGtlwfVBcpomOaWcDWS6ILV3IXioZOtNo_ybJFjOZcq5KTk3JUUiv2XKu2Fsb3mgLxoo_4aW9gZgfwmooFVdeWW1Cb8co1mep2LAjhcYDDZeDHgZtAGroTQedCdLZ_5_5AtMzJBo</recordid><startdate>199207</startdate><enddate>199207</enddate><creator>Fehmann, Hans-C.</creator><creator>Habener, Joel F.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199207</creationdate><title>Insulinotropic glucagonlike peptide-I(7–37)/(7–36)amide A new incretin hormone</title><author>Fehmann, Hans-C. ; Habener, Joel F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c303t-c571c47f75bb02591a2ff646953c09bdb907ee77c5fecb3923a51b9de01831a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Biological and medical sciences</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gastrointestinal hormones</topic><topic>Vertebrates: digestive system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fehmann, Hans-C.</creatorcontrib><creatorcontrib>Habener, Joel F.</creatorcontrib><collection>Pascal-Francis</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in Endocrinology & Metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fehmann, Hans-C.</au><au>Habener, Joel F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insulinotropic glucagonlike peptide-I(7–37)/(7–36)amide A new incretin hormone</atitle><jtitle>Trends in Endocrinology & Metabolism</jtitle><addtitle>Trends Endocrinol Metab</addtitle><date>1992-07</date><risdate>1992</risdate><volume>3</volume><issue>5</issue><spage>158</spage><epage>163</epage><pages>158-163</pages><issn>1043-2760</issn><eissn>1879-3061</eissn><abstract>Intestinal peptide hormones, released into circulation in response to a meal, are important augmentors of the postprandial insulin release stimulated by absorbed nutrients. In this “Incretin concept” glucagon-like peptide I(7–37) plays a major role because it is the most powerful glucose-dependent insulin secretagogue described so far. Glucagonlike peptide I(7–37) also stimulates proinsulin gene expression and proinsulin biosynthesis in insulinoma cells, and it may be involved in the regulation of the intracellular insulin pool of the B cell. Recent studies show elevated levels of glucagonlike peptide I(7–37) in patients with non-insulin-dependent diabetes mellitus. The physiology and pathophysiology of the enteroinsular axis is a promising field of basic and clinical research that has a relevance to diabetes mellitus.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>18407095</pmid><doi>10.1016/1043-2760(92)90165-W</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1043-2760 |
| ispartof | Trends in Endocrinology & Metabolism, 1992-07, Vol.3 (5), p.158-163 |
| issn | 1043-2760 1879-3061 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_734283375 |
| source | Elsevier ScienceDirect Journals Complete |
| subjects | Biological and medical sciences Fundamental and applied biological sciences. Psychology Gastrointestinal hormones Vertebrates: digestive system |
| title | Insulinotropic glucagonlike peptide-I(7–37)/(7–36)amide A new incretin hormone |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A48%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insulinotropic%20glucagonlike%20peptide-I(7%E2%80%9337)/(7%E2%80%9336)amide%20A%20new%20incretin%20hormone&rft.jtitle=Trends%20in%20Endocrinology%20&%20Metabolism&rft.au=Fehmann,%20Hans-C.&rft.date=1992-07&rft.volume=3&rft.issue=5&rft.spage=158&rft.epage=163&rft.pages=158-163&rft.issn=1043-2760&rft.eissn=1879-3061&rft_id=info:doi/10.1016/1043-2760(92)90165-W&rft_dat=%3Cproquest_cross%3E734283375%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=734283375&rft_id=info:pmid/18407095&rft_els_id=104327609290165W&rfr_iscdi=true |